Poster session (2)

Shanghai, September 23-25, 2024.

The poster session will be organized as a live session.

The size of the posters required: Height: 120 cm, width: 80 cm

List of posters:

P-01 Liuhan Dong, Yue Lv, Xiaomei Zhuang
Development of a salbutamol/lidocaine compound inhalant:  Do pharmacokinetic-based drug-drug interactions occur when the two drugs are combined?
P-02 Juanwen Hu, Xue Jiang, Xiaomei Zhuang
Construction and validation of a surrogate Blood-Brain Barrier model utilizing of LLC-PK1-MDR1 cell line and its relevance for drug brain exposure
P-03 Nizar Al-Zoubi, Iman Mansi, Nabil AL-Hashimi, Mai Jaber, Iqbal Abu-Elkbash
Hydrocolloid from leaves of Corchorus olitorius L. as a matrix former for oral sustained drug delivery
P-04 Shiori Ishida, Samuel Lee , Karl Box , Balint Sinko, Kiyohiko Sugano
Flux evaluation of HPMC-AS amorphous solid dispersion using bicarbonate buffer
P-05 Ling Wang, Limeng Zhu, Lihou Dong, Zhihao Liu, Fang Chen, Jing Jiang.
Preclinical Pharmacokinetics, Distribution, Metabolite, Excretion Characterization of Disitamab Vedotin in Rodents
P-06 Yue Gong, Rui Jiang, Rui Hong Guo, Se Jin Jo, Young Ran Kim
TolCV1 inhibition by NPPB renders Vibrio vulnificus less virulent and more susceptible to antibiotics
P-07 Mayu Konishi, Ishikura yosuke, Kiyohiko Sugano
Bile micelle partition coefficient of ionized and unionized drug species
P-08 Evgeniy A. Losev, Daria Ya. Zheltikova, Dmitry S. Kolybalov, Andrey G. Ogienko, Elena V. Boldyreva
A new approach to polymer-assisted mechanochemistry: 3D printed polymer inserts for control of mechanochemical processes
P-09 Shikha Mudgal
A New Carboxylic Acid Group Containing Benzothiazolone Derivatives as Potent Aldose Reductase Inhibitors: Synthesis, In-Vitro, and In-Silico Evaluation
P-10 Nanami Okamoto, Masaki Higashino, Kiyohiko Sugano
Dissolution Profiles of Immediate Release Drug Products in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer
P-11 Rie Takeuchi, Kiyohiko Sugano
Bile micelle and food binding of zwitterionic antihistamine drugs
P-12 Yuki Tarumi, Kiyohiko Sugano
Dissolution profiles of high-dose dissociable drugs in bicarbonate and phosphate buffer solutions
P-13 Hibiki Yamamoto, Kiyohiko Sugano
Effect of pH and buffer capacity of bicarbonate buffer on the precipitation of drugs
P-14 Najmeh Zare, Hassan Karimi-Maleh
A novel modified DNA biosensor modified with MXene nano-layer catalyst for monitoring of Epirubicin breast cancer drug
P-15 Hai-Long Zhang, Henry H. Y. Tong   
Discovery of Novel EGFR and BRAF Inhibitors via Machine Learning and Molecular Docking  
P-16

Konstantin V. Furs, Anna V. Gonchar, Fanke Jiao, Lijue Wang, Qian Wang, Wei Xu, Lu Lu, Shuai Xia, Alexander M. Andrianov, Alexander V. Tuzikov and Shibo Jiang
Computer-aided identification of Navitoclax as potent SARS-CoV-2 fusion inhibitor targeting heptapeptide repeat sequence 1 in S2 protein

P-17
Florentin Lukas Holzem, Neil Parrott, Jeannine Petrig Schaffland, Martin Brandl, Annette Bauer-Brandl, Cordula Stillhart
Oral absorption from surfactant-based drug formulations: the impact of molecularly dissolved drug on bioavailability
P-18

Florentin Lukas Holzem, Jeannine Petrig Schaffland, Martin Brandl, Annette Bauer-Brandl, Cordula Stillhart
Using molecularly dissolved drug concentrations in PBBM modelling improves oral absorption prediction from supersaturating formulations

P-19 Chunyong He, Yuchang Mao, Dan Zeng and Kuan Mei
Preclinical Evaluation of Chemically Reactive Metabolites and  Mitigation of Bioactivation in Drug Discovery